Seoul Pharma Co. Ltd (018680) — Long-term Investment Intensity
Seoul Pharma Co. Ltd (018680) has a Long-term Investment Intensity of 0.4% as of September 2019. Long-term investments of ₩350.71 Million represent 0.4% of total assets of ₩90.42 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 018680 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Seoul Pharma Co. Ltd Long-term Investment Intensity (2012–2018)
This chart shows how Seoul Pharma Co. Ltd's Long-term Investment Intensity has evolved across 7 annual periods from 2012 to 2018. As of September 2019, the intensity stands at 0.4%, reflecting long-term investments of ₩350.71 Million against total assets of ₩90.42 Billion KRW. Explore Seoul Pharma Co. Ltd (018680) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Seoul Pharma Co. Ltd (2012–2018)
The table below presents the year-by-year Long-term Investment Intensity for Seoul Pharma Co. Ltd from 2012 to 2018, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see 018680 market cap overview.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.4% | ₩319.53 Million | ₩90.57 Billion | ▲ +0.0 pp |
| 2017 | 0.3% | ₩278.90 Million | ₩86.93 Billion | ▼ -0.3 pp |
| 2016 | 0.6% | ₩539.40 Million | ₩92.54 Billion | ▼ 0.0 pp |
| 2015 | 0.6% | ₩493.99 Million | ₩82.68 Billion | ▲ +0.0 pp |
| 2014 | 0.6% | ₩456.88 Million | ₩78.98 Billion | ▼ 0.0 pp |
| 2013 | 0.6% | ₩421.00 Million | ₩71.42 Billion | ▼ -0.1 pp |
| 2012 | 0.6% | ₩391.00 Million | ₩60.68 Billion | — |